PET/CT and renal pathology: A blind spot for radiologists? Part 1, primary pathology

Katherine Zukotynski; Aaron Lewis; Kevin O'Regan; Heather Jacene; Christopher Sakellis; Katherine Krajewski; David Israel

doi:10.2214/AJR.11.7790

PET/CT and renal pathology: A blind spot for radiologists? Part 1, primary pathology

Katherine Zukotynski, Aaron Lewis, Kevin O'Regan, Heather Jacene, Christopher Sakellis, Katherine Krajewski, David Israel

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

OBJECTIVE. PET/CT with ¹⁸F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close attention to the CT portion of the study, whereas metabolically active pathology may be missed on PET because of physiologic tracer excretion in the kidneys. This article illustrates primary lesions of the kidney on FDG PET/CT with emphasis on key anatomic features and the appearance of tracer uptake. CONCLUSION. Close attention to both the FDG PET and CT portions of the study is essential to interpret renal pathology correctly on FDG PET/CT examinations.

Original language	English (US)
Pages (from-to)	W163-W167
Journal	American Journal of Roentgenology
Volume	199
Issue number	2
DOIs	https://doi.org/10.2214/AJR.11.7790
State	Published - Aug 2012
Externally published	Yes

Keywords

FDG PET/CT
Oncology
Renal pathology

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2214/AJR.11.7790

Cite this

@article{7e757e9c3bf74f61b6e303997b443ec9,

title = "PET/CT and renal pathology: A blind spot for radiologists? Part 1, primary pathology",

abstract = "OBJECTIVE. PET/CT with 18F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close attention to the CT portion of the study, whereas metabolically active pathology may be missed on PET because of physiologic tracer excretion in the kidneys. This article illustrates primary lesions of the kidney on FDG PET/CT with emphasis on key anatomic features and the appearance of tracer uptake. CONCLUSION. Close attention to both the FDG PET and CT portions of the study is essential to interpret renal pathology correctly on FDG PET/CT examinations.",

keywords = "FDG PET/CT, Oncology, Renal pathology",

author = "Katherine Zukotynski and Aaron Lewis and Kevin O'Regan and Heather Jacene and Christopher Sakellis and Katherine Krajewski and David Israel",

year = "2012",

month = aug,

doi = "10.2214/AJR.11.7790",

language = "English (US)",

volume = "199",

pages = "W163--W167",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "2",

}

TY - JOUR

T1 - PET/CT and renal pathology

T2 - A blind spot for radiologists? Part 1, primary pathology

AU - Zukotynski, Katherine

AU - Lewis, Aaron

AU - O'Regan, Kevin

AU - Jacene, Heather

AU - Sakellis, Christopher

AU - Krajewski, Katherine

AU - Israel, David

PY - 2012/8

Y1 - 2012/8

N2 - OBJECTIVE. PET/CT with 18F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close attention to the CT portion of the study, whereas metabolically active pathology may be missed on PET because of physiologic tracer excretion in the kidneys. This article illustrates primary lesions of the kidney on FDG PET/CT with emphasis on key anatomic features and the appearance of tracer uptake. CONCLUSION. Close attention to both the FDG PET and CT portions of the study is essential to interpret renal pathology correctly on FDG PET/CT examinations.

AB - OBJECTIVE. PET/CT with 18F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close attention to the CT portion of the study, whereas metabolically active pathology may be missed on PET because of physiologic tracer excretion in the kidneys. This article illustrates primary lesions of the kidney on FDG PET/CT with emphasis on key anatomic features and the appearance of tracer uptake. CONCLUSION. Close attention to both the FDG PET and CT portions of the study is essential to interpret renal pathology correctly on FDG PET/CT examinations.

KW - FDG PET/CT

KW - Oncology

KW - Renal pathology

UR - http://www.scopus.com/inward/record.url?scp=84864756590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864756590&partnerID=8YFLogxK

U2 - 10.2214/AJR.11.7790

DO - 10.2214/AJR.11.7790

M3 - Review article

C2 - 22826417

AN - SCOPUS:84864756590

SN - 0361-803X

VL - 199

SP - W163-W167

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

IS - 2

ER -

PET/CT and renal pathology: A blind spot for radiologists? Part 1, primary pathology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this